Skip to main content
OpenTrials

Clinical trial condition

Arthritis, Rheumatoid

Explore clinical trials studying Arthritis, Rheumatoid. Study availability and eligibility vary by location and protocol.

2,458 public trials 233 recruiting studies
Refine in advanced search Browse all conditions

Arthritis, Rheumatoid trial results

Completed

A Study To Evaluate The Effect Of CP-690,550 On Measures Of Kidney Function In Patients With Active Rheumatoid Arthritis

NCT01484561

Conditions
Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +6 more
Locations
  • Pfizer Investigational Site South Miami, Florida, United States
  • Pfizer Investigational Site Albany, New York, United States
  • Pfizer Investigational Site Duncansville, Pennsylvania, United States
  • Pfizer Investigational Site Dallas, Texas, United States
View all 24 locations
View Trial Details
Completed

Assessment of Pain Management in Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis Patients Who Are About to be Treated With Adalimumab

NCT01273519

Conditions
Ankylosing Spondylitis, Ankylosis, Arthritis, +27 more
Locations
  • Site Reference ID/Investigator# 52144 Bludenz, Austria
  • Site Reference ID/Investigator# 44915 Fürstenfeld, Austria
  • Site Reference ID/Investigator# 44910 Gloggnitz, Austria
  • Site Reference ID/Investigator# 44914 Graz, Austria
View all 15 locations
View Trial Details
Completed

A Study to Determine the Effect of Methotrexate (MTX) Dose on Clinical Outcome and Ultrasonographic Signs in Subjects With Moderately to Severely Active Rheumatoid Arthritis (RA) Treated With Adalimumab (MUSICA)

NCT01185288

Conditions
Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +7 more
Locations
  • Site Reference ID/Investigator# 38982 Huntsville, Alabama, United States
  • Site Reference ID/Investigator# 38686 Tuscaloosa, Alabama, United States
  • Site Reference ID/Investigator# 42044 Mesa, Arizona, United States
  • Site Reference ID/Investigator# 37983 Phoenix, Arizona, United States
View all 49 locations
View Trial Details
Completed

A Study of the Safety and Efficacy of Golimumab (CNTO 148) in Subjects With Active Rheumatoid Arthritis Previously Treated With Biologic Anti-TNFa Agent(s)

NCT00299546

Conditions
Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +6 more
Locations
  • Birmingham, Alabama, United States
  • Huntsville, Alabama, United States
  • Paradise Valley, Arizona, United States
  • La Jolla, California, United States
View all 77 locations
View Trial Details

Related conditions